WntResearch AB (NGM:WNT)

Market Cap	4.35M
Revenue (ttm)	n/a
Net Income (ttm)	-44.02M
Shares Out	8.67M
EPS (ttm)	-6.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,667
Average Volume	41,102
Open	0.540
Previous Close	0.600
Day's Range	0.421 - 0.600
52-Week Range	0.401 - 17.200
Beta	0.46
RSI	35.31
Earnings Date	Feb 7, 2025

About WntResearch AB

WntResearch AB, a biotech company, develops therapies to prevent the metastatic process. The company develops Foxy-5, a peptide, which is in Phase II clinical trials that reduced the risk of metastasis in patients with colon cancer. It is also developing Box-5, a WNT5A antagonist for the treatment of malignant melanoma, and pancreatic and gastric cancer. The company was incorporated in 2007 and is based in Lund, Sweden.

• Industry: Other
• Founded: 2007
• Employees: 2
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: WNT